Becton Dickinson and Co (NYSE:BDX)
| 245.22 BATS BZX Real-Time Price As of 9:56am ET |  +3.46 / +1.43%Today’s Change | 215.90 Today|||52-Week Range 269.06 | -3.57% Year-to-Date |
Latest BDX News | Press Releases
| BD's (BDX) Latest Product Launch to Boost Research Outcome May 22 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 241.76 |
| Today’s open | 243.77 |
| Day’s range | 243.41 - 245.83 |
| Volume | 150,211 |
| Average volume (3 months) | 1,109,935 |
| Market cap | $68.5B |
Data as of 9:56am ET, 06/01/2023
Growth & Valuation
| Earnings growth (last year) | -14.37% |
| Earnings growth (this year) | +7.56% |
| Earnings growth (next 5 years) | +9.60% |
| Revenue growth (last year) | -6.81% |
| P/E ratio | 45.0 |
| Price/Sales | 3.39 |
| Price/Book | 2.70 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BSXBoston Scientific Co... | -0.48 | -0.93% |
| DXCMDexcom Inc | -0.18 | -0.15% |
| ZBHZimmer Biomet Holdin... | -0.64 | -0.50% |
| WSTWest Pharmaceutical ... | +1.37 | +0.41% |
Data as of 9:57am ET, 06/01/2023
Financials
| Next reporting date | August 3, 2023 |
| EPS forecast (this quarter) | $2.90 |
| Annual revenue (last year) | $18.9B |
| Annual profit (last year) | $1.8B |
| Net profit margin | 8.66% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Franklin Lakes, New Jersey |
Forecasts
